Skip to content
easybpt
Browse topics

Nephrology

Diabetic kidney disease

Screening with ACR and eGFR, when the kidney disease probably isn't diabetic, and the four drug pillars (RAS blockade, SGLT2 inhibitor, finerenone, GLP-1 receptor agonist) with their trials.

Tier 1Condition

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions9 flashcards

At a glance

  • Diabetes causes about 40% of new kidney failure in Australia, and over 70% in First Nations Australians (KHA 2024). About 1 in 3 people with diabetes develop CKD.
  • Diagnose on persistent albuminuria and/or reduced eGFR in a person with diabetes, usually with retinopathy, after excluding other causes.
  • Treatment rests on four pillars: maximum tolerated ACE inhibitor or ARB, an SGLT2 inhibitor, and in type 2 diabetes finerenone and a GLP-1 receptor agonist. Add BP control, a statin and individualised glucose targets.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions9 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.